Shishir Gadam

Shishir Gadam, Ph.D., is the Chief Technical Officer of Syncopation Life Sciences. He is a seasoned Biotechnology leader with over 25 years of experience and brings a wealth of CMC experience across vaccines, biologics, and cell therapy modalities. Shishir is passionate about developing employees, building strong technical teams, and accelerating the development and commercialization of new products and technology. Most recently he was the Vice President of Global Cell Therapy Manufacturing Science and Technology at BMS (which acquired Celgene and Juno Therapeutics). He played an instrumental role in the global licensure and launch of the CAR T products Breayanzi® and Abecma® and built a global technical organization responsible for product life cycle management, commercialization, technology transfers, and support of internal and external manufacturing. Prior to BMS, Shishir was at Genentech/Roche from 2006 to 2018 in various global leadership roles in Biologics Technical Development and Operations focused on CMC life cycle management, manufacturing science, new facility startup, technology transfers, and Site Operations. Shishir established technical teams in multiple countries and interacted with global health authorities to support Roche’s Biologics portfolio, including critical new launches of Actemra®, Perjeta®, Ocrevus®, Tecentriq®. Prior to Genentech, he was at Merck and Company’s Vaccine/Bioprocess Technical Development Organization and played a key role in the development and approval of critical vaccines including Gardasil®.

Shishir earned his Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute, Masters's in Chemical Engineering from West Virginia University, and B.S. in Chemical Engineering from the Institute of Chemical Technology, India. In 2017, he was inducted into the AIMBE College of Fellows for his outstanding contributions to developing, scaling up, designing, and starting up manufacturing processes and factories, along with defining the product technology lifecycle strategy for multiple products.

Shishir Gadam is the CTO at CARGO Therapeutics, based in United States, North America. With a background in Biotechnology, Shishir Gadam has a rich history of leadership and innovation.Shishir Gadam studied PhD Biochemical Engineering at Rensselaer Polytechnic Institute. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.